Skip to content
10-K

Annual Report

Icagen, Inc.

0001213900-19-006256

← back to feed
Filed
Apr 12, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Apr 12, 2019 6.39M sh
Capex FY 2018 · Dec 31, 2018 $1.29M
Capex FY 2018 · Dec 31, 2017 $1.24M
Operating Cash Flow FY 2018 · Dec 31, 2018 −$4.2M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$10M
Long Term Debt FY 2018 · Dec 31, 2018 $12.71M
Cash And Equivalents FY 2018 · Dec 31, 2018 $4.12M
Cash And Equivalents FY 2018 · Dec 31, 2017 $2.76M
Cash And Equivalents FY 2018 · Dec 31, 2016 $4.94M
Stockholders Equity FY 2018 · Dec 31, 2018 −$19.36M
Stockholders Equity FY 2018 · Dec 31, 2017 −$8.67M
Stockholders Equity FY 2018 · Dec 31, 2016 −$3.53M
Current Liabilities FY 2018 · Dec 31, 2018 $10.94M
Current Liabilities FY 2018 · Dec 31, 2017 $4.97M
Total Liabilities FY 2018 · Dec 31, 2018 $34.97M
Total Liabilities FY 2018 · Dec 31, 2017 $23.31M
Current Assets FY 2018 · Dec 31, 2018 $6.34M
Current Assets FY 2018 · Dec 31, 2017 $4.79M
Total Assets FY 2018 · Dec 31, 2018 $15.62M
Total Assets FY 2018 · Dec 31, 2017 $14.64M
Sga Expense FY 2018 · Dec 31, 2018 $10.31M
Sga Expense FY 2018 · Dec 31, 2017 $13.94M
Net Income FY 2018 · Dec 31, 2018 −$13.04M
Net Income FY 2018 · Dec 31, 2017 −$6.11M
Operating Income FY 2018 · Dec 31, 2018 −$8.5M
Operating Income FY 2018 · Dec 31, 2017 −$4.42M
Gross Profit FY 2018 · Dec 31, 2018 $3.67M
Gross Profit FY 2018 · Dec 31, 2017 $11.48M
Revenue FY 2018 · Dec 31, 2018 $13.58M
Revenue FY 2018 · Dec 31, 2017 $22.66M